Project Grant R03TR005223
- The Project Grant award titled "MECHANISTIC ASSESSMENT OF RETINAL GANGLION CELL GENESIS" is funded by the National Eye Institute (NEI) under the Vision Research federal grant program (CFDA 93.867). The $428,349 award supports a research project at the Medical College of Wisconsin, Inc. (MCW) to investigate the genetic factors and regulatory networks required for the development of retinal ganglion cells (RGCs), which are essential for vertebrate vision. The 5-year project aims to...
- This Project Grant award from the National Center for Advancing Translational Sciences (NCATS), under CFDA Program 93.350, provides $158,750.00 to the University of Texas at Austin to conduct research on the function of the CACNA2D4 gene and its role in inherited retinal dystrophies. The overarching goal is to gain insight into the pathophysiological mechanisms of CACNA2D4-associated inherited retinal disorders by elucidating the structure-function relationships of the A2D-4 protein, which is...
- This federal Project Grant award of $526,841 from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) is supporting research by Vanderbilt University Medical Center to investigate the role of cyclic guanosine monophosphate (cGMP) signaling in glaucomatous neurodegeneration. The research aims to probe the mechanisms of retinal ganglion cell (RGC) degeneration in glaucoma, with the objective of identifying novel therapeutic targets to protect and potentially restore...
- The National Eye Institute (NEI) awarded a $902,000 Project Grant under the Vision Research federal grant program (CFDA 93.867) to the University of California, San Francisco (UCSF) to conduct research on a novel inherited mouse model of glaucoma. The project aims to characterize the glaucoma-relevant phenotypes in GLIS1 knockout mice, including evaluating structural and functional changes such as axonal degeneration, retinal ganglion cell loss, and neuroinflammatory responses. Additionally, the...
- This Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) provides funding to Human Cell Co, a for-profit biotechnology research company, to develop a combination therapy for glaucoma. The award, totaling $360,897, will support research to determine if topical application of a nerve growth factor (NGF) mutein (HC201) in combination with oral nicotinamide (NAM) supplementation can more effectively improve retinal ganglion cell function compared to either treatment...
- This $618,088 federal Project Grant award from the National Eye Institute's Vision Research program (CFDA 93.867) will support research at the University of Texas Medical Branch at Galveston on the role of mitochondrial DNA and the protein ZBP1 in retinal neurodegeneration associated with glaucoma. The research aims to test the hypothesis that damaged mitochondrial DNA acts as an immune factor, binding to ZBP1 and contributing to retinal ganglion cell degeneration in glaucoma. The study will...
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded Emory University a $430,375 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to study disease-associated mutations and ligand activation of the adhesion G protein-coupled receptor ADGRB2. The key objectives are to: Investigate newly identified patient mutations in the ADGRB2 gene that are associated with spastic paraparesis and other neurological symptoms,...
- This $460,625 Project Grant was awarded by the National Eye Institute (NEI) under the Vision Research federal grant program (CFDA 93.867) to Yale University. The grant will fund research to investigate the cellular and synaptic mechanisms underlying changes in retinal ganglion cell (RGC) activity following optic nerve injuries in mouse models of glaucoma. Specifically, the project aims to (1) determine the underlying mechanisms for altered RGC activity after increased intraocular pressure or...
- The Regents of the University of California, Berkeley has been awarded a $632,806 Project Grant from the National Science Foundation's (NSF) Biological Sciences (CFDA 47.074) program to conduct research on the diversification of retinal ganglion cells in the zebrafish neural retina. This 5-year project will use single-nucleus RNA sequencing, genome engineering, and live imaging techniques to map the transcriptional landscapes and lineage relationships among the approximately 35-50 distinct types...
- This federal Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), will support research to understand the molecular mechanisms that control the development of specific subtypes of photoreceptor neurons for color vision in the Drosophila melanogaster retina. The $435,052 grant awarded to the University of Massachusetts Boston aims to decipher the gene regulatory network and identify conserved transcription factors that specify...
CONDITIONAL KNOCK-IN OF GNB3/GNGT2 IN MOUSE ROD PHOTORECEPTORS - ABSTRACT. THE G-PROTEIN GB3 SUBUNIT ENCODED BY THE GENE GNB3, IS THE PROTEIN PRESENT IN MULTIPLE TISSUES AND CELL TYPES, INCLUDING RETINAL CONE PHOTORECEPTORS, AS PART OF THE GABG HETEROTRIMERS RESPONSIBLE FOR THE INTRACELLULAR SIGNALING INITIATED BY THE G-PROTEIN-COUPLED RECEPTORS, GPCRS. THERE IS EVIDENCE THAT MUTATIONS IN GNB3 ARE ASSOCIATED WITH CARDIOVASCULAR DISEASE, METABOLIC SYNDROME, OBESITY AND VISUAL IMPAIRMENT. RARE GNB3 MUTATIONS HAVE BEEN FOUND ASSOCIATED WITH RETINAL DEGENERATION AND CONGENITAL STATIONARY NIGHT BLINDNESS. THE MECHANISMS OF THESE PATHOPHYSIOLOGICAL CONDITIONS LINKED TO GNB3 ARE POORLY UNDERSTOOD. IN THE RETINA, THERE IS LITTLE UNDERSTANDING OF WHY MEMBERS OF THE SAME GENE FAMILY GNB3 AND GNB1 ARE EXPRESSED SELECTIVELY IN CONE AND ROD PHOTORECEPTORS, AND WHAT ROLES GB3 AND GB1, IN TIGHT COMPLEXES WITH THE CORRESPONDING GG SUBUNIT, GGC AND GG1, CONTRIBUTE TO THE DISTINCT PROPERTIES OF CONE AND ROD PHOTOTRANSDUCTION AND RETINAL DISEASES. THIS PILOT PROPOSAL FOCUSES ON THE INITIAL CHARACTERIZATION OF A UNIQUE MOUSE MODEL THAT OUR LABORATORY HAS DEVELOPED TO REPLACE THE ENTIRE ROD GB1G1 SUBUNIT COMPLEX WITH ITS CONE ANALOGUE GB3GC. THE PROPOSAL AIMS TO COLLECT CRITICAL PRELIMINARY DATA FOR A MORE COMPREHENSIVE PROJECT FOCUSING ON THE SPECIFICITY OF RETINAL SIGNALING AND MECHANISMS OF RETINAL DISORDERS INVOLVING GNB3. THIS PROJECT BUILDS THE NECESSARY FOUNDATION FOR FURTHER MECHANISTIC STUDIES OF SPECIFIC HUMAN MUTATIONS, AS WELL AS THE DEVELOPMENT OF NEW THERAPEUTIC APPROACHES.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 7/24/25 | ||
| Not listed | $151.5k | 7/24/24 |